Development and Characterization of Gastro-Retentive Blend Microparticles of Sumatriptan: Design, Optimization, ex vivo, and in vitro Evaluation for Oral Drug Delivery

Migraine is a complex neurological disorder of the brain which is often accompanied with headache, gastrointestinal, neurologic, and sometime aural symptoms [1, 2]. Sumatriptan (ST) is a serotonin receptor agonist (5-hydroxytryptamine or 5-HT receptor) used to treat migraine and cluster headaches [3]. However, ST is rapidly but incompletely absorbed following oral administration (15%) because of the high first-pass metabolism [4]. On the other hand, a large number of patients suffer from nausea and vomiting during multiple migraine attacks, which may result in inadequate absorption of ST in oral therapy. The sustained release drug delivery systems for ST can be useful to reduce dosing frequency, enhance drug oral bioavailability, minimize gastrointestinal adverse effects, and improve the effectiveness of drug in the management of migraine. However, a major problem commonly associated with the conventional sustained release drug delivery systems is a shorter mean retention time in the stomach. Moreover, traditional oral preparations lead to large fluctuations in the plasma drug level [5]. Thus, increasing the retention time of dosage form in the stomach while improving their stability in the gastric medium is an excellent strategy to bypass this problem. Various gastroretentive drug delivery systems including expanding and swelling systems, floating drug delivery systems, mucoadhesive systems, and modified-shape systems have been proposed to improve the gastric retention time of drugs [6]. Among gastro-retentive systems, microparticles with floating and mucoadhesive capabilities have attracted large interest owing to their capacity to interact with the mucosal site, improving the retention time of drug in the stomach for a long period of time. Afterwards, the payload is slowly released at the specific time and rate from the carrier. This leads to a large concentration gradient which C o r re s p o n d e n c e

[1]  K. Chowdoji Rao,et al.  Curcumin encapsulated dual cross linked sodium alginate/montmorillonite polymeric composite beads for controlled drug delivery , 2020, Journal of pharmaceutical analysis.

[2]  P. Sharma,et al.  Recent Advances and Novel Approaches for Nose to Brain Drug Delivery for Treatment of Migraine , 2019, Drug Delivery Letters.

[3]  István Antal,et al.  Microparticles, Microspheres, and Microcapsules for Advanced Drug Delivery , 2019, Scientia Pharmaceutica.

[4]  M. Edirisinghe,et al.  Electrosprayed microparticles: a novel drug delivery method , 2019, Expert opinion on drug delivery.

[5]  B. Vigani,et al.  Recent advances in the mucus-interacting approach for vaginal drug delivery: from mucoadhesive to mucus-penetrating nanoparticles , 2019, Expert opinion on drug delivery.

[6]  F. Goycoolea,et al.  Interaction Between Chitosan and Mucin: Fundamentals and Applications , 2019, Biomimetics.

[7]  R. Burch Migraine and Tension-Type Headache: Diagnosis and Treatment. , 2019, The Medical clinics of North America.

[8]  K. Adibkia,et al.  An Alternative Approach for Improved Entrapment Efficiency of Hydrophilic Drug Substance in PLGA Nanoparticles by Interfacial Polymer Deposition Following Solvent Displacement , 2018, Jundishapur Journal of Natural Pharmaceutical Products.

[9]  S. Salatin,et al.  Box–Behnken experimental design for preparation and optimization of the intranasal gels of selegiline hydrochloride , 2018, Drug development and industrial pharmacy.

[10]  P. Martelletti,et al.  Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential , 2018, Journal of pain research.

[11]  David Julian McClements,et al.  Delivery by Design (DbD): A Standardized Approach to the Development of Efficacious Nanoparticle- and Microparticle-Based Delivery Systems. , 2018, Comprehensive reviews in food science and food safety.

[12]  S. Salatin,et al.  Natural Polysaccharide based Nanoparticles for Drug/Gene Deliv­ery , 2017 .

[13]  Marius Majewsky,et al.  Determination of microplastic polyethylene (PE) and polypropylene (PP) in environmental samples using thermal analysis (TGA-DSC). , 2016, The Science of the total environment.

[14]  E. Injeti,et al.  Development and evaluation of a calcium alginate based oral ceftriaxone sodium formulation , 2016, Progress in Biomaterials.

[15]  M. Mannan,et al.  Development of Floating-Mucoadhesive Microsphere for Site Specific Release of Metronidazole. , 2016, Advanced pharmaceutical bulletin.

[16]  J. Khanam,et al.  Study of the Mucoadhesive Potential of Carbopol Polymer in the Preparation of Microbeads Containing the Antidiabetic Drug Glipizide , 2016, AAPS PharmSciTech.

[17]  Lídia M D Gonçalves,et al.  Effect of Experimental Parameters on Alginate/Chitosan Microparticles for BCG Encapsulation , 2016, Marine drugs.

[18]  S. Singh,et al.  A Comparative Study of Orally Delivered PBCA and ApoE Coupled BSA Nanoparticles for Brain Targeting of Sumatriptan Succinate in Therapeutic Management of Migraine , 2016, Pharmaceutical Research.

[19]  Yuan-Lu Cui,et al.  Mucoadhesive Microparticles for Gastroretentive Delivery: Preparation, Biodistribution and Targeting Evaluation , 2014, Marine drugs.

[20]  Nidhi,et al.  Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review , 2014, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[21]  J. R. Miranda,et al.  A novel automated alternating current biosusceptometry method to characterization of controlled-release magnetic floating tablets of metronidazole , 2014, Drug development and industrial pharmacy.

[22]  M. L. González-Rodríguez,et al.  Robust Optimization of Alginate-Carbopol 940 Bead Formulations , 2012, TheScientificWorldJournal.

[23]  V. Bhaskar,et al.  Preparation and in vitro Characterization of Porous Carrier–Based Glipizide Floating Microspheres for Gastric Delivery , 2011, Journal of young pharmacists : JYP.

[24]  J. Patel,et al.  Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy , 2009, Journal of microencapsulation.

[25]  N. Henry,et al.  Poly ϵ -Caprolactone Microparticles Containing Biosurfactants: Optimization of Formulation Factors , 2009 .

[26]  M. K. Das,et al.  Microencapsulation of zidovudine by double emulsion solvent diffusion technique using ethylcellulose , 2007 .

[27]  Juergen Siepmann,et al.  Gastroretentive drug delivery systems , 2006, Expert opinion on drug delivery.

[28]  M. Özyazıcı,et al.  Bioadhesive Controlled Release Systems of Ornidazole for Vaginal Delivery , 2006, Pharmaceutical development and technology.

[29]  A. Nokhodchi,et al.  In situ cross-linking of sodium alginate with calcium and aluminum ions to sustain the release of theophylline from polymeric matrices. , 2004, Farmaco.

[30]  N A Peppas,et al.  Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). , 2001, Advanced drug delivery reviews.

[31]  Matti Hoch,et al.  Advanced Drug Delivery Reviews , 2017 .

[32]  Chen Xia,et al.  The pH-responsive alginate hydrogel prepared through solution extrusion and the release behavior for different drugs , 2016 .

[33]  V. Pandit,et al.  Mucoadhesive microparticulate drug delivery system of curcumin against Helicobacter pylori infection: Design, development and optimization , 2014, Journal of advanced pharmaceutical technology & research.

[34]  A. Gonzalez-Alvarez,et al.  Swelling characterization and drug delivery kinetics of polyacrylamide-co-itaconic acid/chitosan hydrogels , 2009 .

[35]  S. F. Zawadzki,et al.  Physicochemical characterization of a hydrophilic model drug-loaded PHBV microparticles obtained by the double emulsion/solvent evaporation technique , 2008 .